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Unlike weak D and partial D, DEL represents a weakened form 
of D that cannot be detected by conventional serology and 
requires use of an adsorption-elution method for its detection; 
therefore, DEL+ samples might be mistyped as D–. The study was 
undertaken to determine the prevalence of the DEL phenotype 
among D– blood donors from northern India. A total of 1003 
D– blood donors were tested for weak D and DEL by the indirect 
antiglobulin test and an adsorption-elution method, respectively. 
Of the total 21,135 blood donors typed for D, 20,132 (95.3%) were 
D+ and 1003 (4.7%) gave a negative reaction for D. Of the total 
1003 D– samples, 8 (0.8%) were weak D and only 2 (0.2%) were 
DEL+ by adsorption-elution testing. For samples that typed as 
D–, the majority of individuals (91.1%) were cde/cde (rr) followed 
by dCe/dce (r ŕ) in 4.8 percent, and dCe/dCe (r ŕ´) in 2.2 percent. 
Both DEL+ samples were also C+. We conclude that the prevalence 
of the DEL phenotype as detected by serology in D– north Indian 
blood donors is 0.2 percent, although it is as high as 2.8 percent 
in D–C+ individuals. There is an association of DEL with C, 
which can be used as a cost-effective marker for screening large 
numbers of D– blood donors for DEL. Immunohematology 
2020;36:133–136.
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Since the identification of the Rh factor more than seven 
decades ago, individuals are categorized as either D+ or D– 
depending on the presence or absence of D. D, in the Rh blood 
group system, is the most immunogenic of all blood group 
antigens. As little as 0.1–1 mL of D+ red blood cells (RBCs) can 
induce anti-D formation in D– recipients, which is responsible 
for severe transfusion reactions and hemolytic disease of the 
fetus and newborn.1
Antigen expression in the Rh system is influenced by two 
homologous RH genes: RHD and RHCE. The high degree of 
homology and opposite orientation of the two genes leads 
to the production of numerous Rh variants.2 D variants are 
usually classified as weak D, partial D, and DEL. Unlike weak 
D and partial D, DEL represents a weakened form of D that 
cannot be detected by conventional serology and requires 
the use of an adsorption-elution method; therefore, it is DEL 
(D-elute).3,4 The first examples of DEL+ RBCs were reported 
in the early 1980s when blood samples negative for D by the 
indirect antiglobulin test (IAT) were found to be positive by 
adsorption-elution.3
Until recently, DEL was primarily described in Asians, 
since a significant proportion of D– Asian individuals are in 
fact DEL+.5–7 In Caucasians, DEL is very rare, although recent 
molecular studies show that the prevalence of DEL in donors 
typed D– in routine testing is greater than initially thought.8,9
Molecular studies have shown that a heterogeneous array 
of variant RHD alleles can result in DEL expression.10 DEL is 
more frequently found in Asians and accounts for 30 percent 
of the D– Asian population, with the most frequent mutation 
being c.1227G>A, a single nucleotide variant associated with 
exon 9 skipping. Hence, it is also called Asia-type DEL.11,12 
This DEL variant occurs with a reported prevalence of 1:110 
in the Chinese Han population. Shao et al.6 deduced that DEL 
is a type of weak D with very few D sites on the RBCs. It has 
been shown that DEL+ RBCs express fewer than 30 D sites 
per RBC compared with 10,000–30,000 sites on normal D+ 
RBCs.
The majority of DEL+ donors are misinterpreted as D– 
owing to the limits of routine serologic typing and therefore 
are included in the pool of D– blood donors. Although a rare 
occurrence, DEL+ RBCs are capable of alloimmunization, 
producing anti-D if transfused to an individual with a truly 
D– phenotype. Reports of anti-D formation after transfusion 
of DEL+ RBCs in recipients with a truly D– phenotype are 
available in the literature.13–15 Therefore, it is important to 
know the prevalence of DEL in the D– population in India.
Barring two reports,16,17 there is paucity of data from the 
Indian population with respect to the occurrence of DEL. The 
aim of the present study was to determine the prevalence of 
DEL+ donors in D– north Indian blood donors.
Material and Methods
A total of 21,135 donors who donated blood at our center 
were typed for D using commercially available monoclonal 
antisera (Anti-D duo IgG + IgM, Rhofinal; Tulip Diagnostics, 
Goa, India). All blood samples negative for D were further 
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n = 20,132 (95.3%)
True D
n = 993 (99%)
DEL+
n = 2 (0.2%)
Weak D (IAT+)
n = 8 (0.8%)
D–
n = 1003 (4.7%)
IAT = indirect antiglobulin test.
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subjected to weak D testing by IAT using the conventional 
tube test (CTT). Rh phenotyping was performed on all 
samples using monoclonal antisera (Series 1 Anti-D, Anti-C, 
Anti-c, Anti-E, and Anti-e; Immucor, Norcross, GA) by CTT 
following the manufacturer’s instructions. The study was 
conducted after approval by the institutional ethics committee 
for postgraduate thesis and obtaining informed consent from 
the blood donors.
All donors whose samples tested as D– and gave negative 
reaction by IAT were further analyzed for DEL by adsorption-
elution testing using the CTT.
Adsorption-Elution Testing
Our procedure follows that of Gowland et al.18 Sample 
RBCs were washed three times in 0.9 percent NaCl, mixed 
with anti-D (Anti-D duo IgM/IgG; Goa, India) at 1:3 (vol:vol), 
and incubated at 37°C for 60 minutes. After six wash cycles 
using saline, the RBC pellet was re-suspended in cold (4°C) 
0.9 percent NaCl at 1:1 (vol:vol). The suspension was then 
completed with cold (4°C) glycine/HCl buffer, 0.1 M, pH 3.0, 
at 1:1 (vol:vol) and incubated in ice water (<4°C) for 1 minute. 
After centrifugation (3000 rpm) for 2 minutes, the recovered 
supernatant was neutralized with Na2HPO4/KH2PO4 buffer 
0.8 M, pH 8.2, at 10:1 (vol:vol) and assessed for the presence 
of anti-D. If the eluate contained anti-D, the expression of 
DEL was confirmed.18 The CTT was used to test the eluate 
and last wash supernatant by IAT against D+ and D– control 
RBCs. An eluate that showed agglutination (≥1+) with D+ 
RBCs was interpreted as serologic DEL+ and an eluate with 
no agglutination as true D–. Last wash supernatant acted as a 
negative control; no agglutination with both D+ and D– RBCs 
validated the eluate results.
Results
Of a total of 21,135 blood donor samples typed for D, 
20,132 (95.3%) were D+, and 1003 (4.7%) samples gave 
a negative reaction for D. Among the 1003 D– samples, 8 
(0.8%) were weak D and only 2 (0.2%) samples were DEL+ 
on adsorption-elution testing. The remaining 993 (99%) were 
truly D– (Fig. 1). The prevalence of DEL as detected by the 
adsorption-elution method in D– north Indian blood donors 
was 0.2 percent; although in D–C+ individuals, it was as high 
as 2.8 percent (2 of 70 D–C+).
Table 1 shows the phenotypes of all D– samples including 
DEL. The majority of the individuals (91.1%) were cde/cde (rr), 
followed by dCe/dce (r ŕ) in 4.8 percent and dCe/dCe (r ŕ )́ in 
2.2 percent. The antigen prevalence of C and c was 6.9 and 
97.8 percent, respectively, and the antigen prevalence of E and 
e was 1.8 and 99.5 percent, respectively. Both DEL+ samples 
were also C+.
Discussion
It is important to identify individuals who are DEL+ 
among D– individuals, since DEL+ RBCs are known to cause 
alloimmunization when transfused to D– recipients.
The prevalence of DEL+ donors in our D– blood donor 
population was low (0.2%). This finding is in agreement with 
other reports from India.17 Samir et al.16 reported a relatively 
high prevalence (1.5%) of DEL+ donors in their D– blood 
donors, whereas Kulkarni et al.17 did not find any DEL+ 
donors in 900 D– donors from west India. This variation in 
the prevalence of DEL in Indian studies could be due to the 
type of reagents used for D typing, the method of elution, and 
ethnic differences in the population. Samir et al.16 used a heat 
elution method, whereas Kulkarni et al.17 used ether elution in 
Table 1. Rh phenotypes in D– individuals including DEL
Phenotype n (%) DEL+ n (%)
dce/dce (rr) 914 (91.1) 0
dCe/dce (rʹr) 48 (4.8) 1 (2)
dCe/dCe (rʹrʹ) 22 (2.2) 1 (4.5)
dcE/dce (rʺr) 14 (1.4) 0
dcE/dcE (rʺrʺ) 5 (0.5) 0
Total 1003 2 (0.2)
IMMUNOHEMATOLOGY, Volume 36, Number 4, 2020 135
Prevalence of DEL in India
their studies. A cold acid (glycine/HCl) method was used for 
elution in our study. The RBC components prepared from the 
two DEL+ blood donors in our study were transfused to D+ 
recipients.
On comparing with the other Asian populations, the 
prevalence of DEL in our blood donors is very low (i.e., 0.2%). In 
studies from Japanese3 and Hong Kong Chinese donors,19 the 
prevalence was found to be as high as 10.3 and 29.3 percent, 
respectively. In yet another study, Sun et al.5 reported a very 
high prevalence of DEL (32.6%) among apparently D– Chinese 
in Taiwan.
Molecular methods have identified RHD*01EL.01 and 
RHD*01EL.46 as the most frequent DEL alleles in the East 
Asian population and in Caucasians, respectively. In a study 
from India,17 none of the 900 D– individuals who were screened 
for these two common DEL mutations (RHD*01EL.01 and 
RHD*01EL.46) were positive, indicating that other types of 
mutations may be responsible for the DEL variant in India.
The association of DEL and C was first described by Okubo 
et al. in 1984,3 and this was subsequently confirmed by many 
studies. In a Taiwanese study,12 DEL was most commonly seen 
in the dCe/dce phenotype, followed by the dCe/dCe, whereas 
in our study, two DEL+ examples were seen: one in dCe/dce 
and one in dCe/dCe.
Another study from Europe20 demonstrated that the 
prevalence of DEL is much higher among D– blood donors 
whose RBCs express C and/or E, concluding that DEL was 
associated with a Cde or cdE haplotype. Our results are also 
in agreement with this observation, as both DEL+ expessions 
were in association with C.
However, the association of DEL with E shows consider-
able ethnic variability—3.7 percent in Chinese21 and 2.6 percent 
in Taiwanese12 individuals—whereas in Korean22 individuals, 
it is 28.6 percent. None of our DEL+ samples were E+.
Because all DEL+ samples express C, the D–C+ phenotype 
can be a useful marker to screen large numbers of D– donors 
for DEL in resource-poor settings.
Conclusion
We conclude that the prevalence of DEL+ donors as 
detected by the adsorption-elution method in D– north Indian 
blood donors is 0.2 percent, although in D–C+ individuals, it 
is as high as 2.8 percent. There is an association of DEL with 
C, but large numbers of samples need to be studied to ascertain 
whether this association can be used as a cost-effective marker 
for screening of D– blood donors for DEL.
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